Rockwell Medical Q1 Adj $(0.02) Beats $(0.04) Estimate, Sales $22.68M Beat $21.70M Estimate
Rockwell Medical Q1 Adj $(0.02) Beats $(0.04) Estimate, Sales $22.68M Beat $21.70M Estimate
羅克韋爾醫療第一季度調整後美元（0.02）超過預期（0.04），銷售額2,268萬美元超過2170萬美元的預期
Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 80 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $22.68 million which beat the analyst consensus estimate of $21.70 million by 4.50 percent. This is a 15.29 percent increase over sales of $19.67 million the same period last year.
羅克韋爾醫療（納斯達克股票代碼：RMTI）公佈的季度虧損爲每股0.02美元，比分析師普遍預期的0.04美元（0.04美元）高出50％。這比去年同期每股虧損0.10美元（0.10）增加了80％。該公司公佈的季度銷售額爲2,268萬美元，比分析師普遍預期的2170萬美元高出4.50％。這比去年同期的1,967萬美元的銷售額增長了15.29％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。